Innoviva Inc

Отворен

СекторЗдравеопазване

21.33 -0.09

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

21.02

Максимум

21.46

Ключови измерители

By Trading Economics

Приходи

-270M

-83M

Продажби

22M

120M

P/E

Средно за сектора

4.819

56.659

EPS

0.59

Марж на печалбата

-69.754

Служители

159

EBITDA

28M

267M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+90.49% upside

Дивиденти

By Acuity

Следващи печалби

3.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-32M

1.5B

Предишно отваряне

21.42

Предишно затваряне

21.33

Настроения в новините

By Acuity

69%

31%

301 / 340 Класиране в Healthcare

Innoviva Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.09.2026 г., 19:26 ч. UTC

Innoviva Inc shares are higher during Tuesday's session, reflecting positive trading momentum despite no specific company news. Broader market factors may influence investor sentiment.

31.08.2026 г., 19:46 ч. UTC

Shares of Innoviva Inc. are lower amid broader market unease following Federal Reserve Chair Kevin Warsh's hawkish remarks at the Jackson Hole symposium.

27.08.2026 г., 20:07 ч. UTC

Innoviva Inc shares are lower today despite a drop in initial jobless claims, indicating resilience in the labor market. The stock reached a session low earlier.

26.08.2026 г., 21:01 ч. UTC

Innoviva Inc shares moved lower in after-market trading, retracing from an initial uptick to reach their lowest point by 16:50 ET.

25.08.2026 г., 21:02 ч. UTC

Innoviva Inc shares are trading lower in after-market hours. No specific company news was identified to explain this movement.

21.08.2026 г., 19:46 ч. UTC

Innoviva Inc's shares are higher during Friday's session, reflecting a modest increase since Thursday's close. No specific news was identified for the movement.

20.08.2026 г., 20:02 ч. UTC

Shares of Innoviva Inc are declining amid broader market pressures following Walmart Inc's disappointing earnings report, raising concerns about consumer spending.

19.08.2026 г., 19:26 ч. UTC

Innoviva Inc's shares are higher during Wednesday's session, maintaining strength above the 20-day moving average and near the upper end of its one-month range.

18.08.2026 г., 20:06 ч. UTC

Innoviva Inc is trading higher, supported by strength in the Pharmaceuticals sub-sector. The stock has shown a steady rise since Monday's close.

14.08.2026 г., 19:56 ч. UTC

Innoviva Inc shares are higher during Friday's session, recovering from earlier losses despite no specific news. Broader market sentiment is affected by declining U.S. retail sales.

13.08.2026 г., 19:41 ч. UTC

Innoviva Inc shares are lower during Thursday's session, with no specific news identified. The stock remains below its 20-day moving average.

12.08.2026 г., 19:06 ч. UTC

Event

Innoviva Inc's therapies are finalists for the 2026 Prix Galien USA Award, but shares are trading lower, remaining below Tuesday's close.

11.08.2026 г., 19:16 ч. UTC

Innoviva Inc's shares are higher in Tuesday's session, reflecting a modest gain since Monday's close. The stock remains below its 20-day moving average.

10.08.2026 г., 19:16 ч. UTC

News

Innoviva shares are higher despite mixed analyst ratings and a price target cut from Cantor Fitzgerald to $34.00. HC Wainwright maintains a $46.00 target.

7.08.2026 г., 21:01 ч. UTC

Innoviva Inc shares are lower in after-market hours, reflecting a decline since Friday's close and trading near the lower end of their one-month range.

6.08.2026 г., 19:51 ч. UTC

News

Innoviva Inc shares are higher as the company shifts to a diversified healthcare model, supported by $773 million in investments and positive momentum since Wednesday.

5.08.2026 г., 21:01 ч. UTC

Innoviva Inc shares are trading higher in after-market hours, recovering from a session low. No specific news was identified to explain the movement.

3.08.2026 г., 19:46 ч. UTC

News

Innoviva Inc shares are lower today, continuing a downward trend. Analysts from BTIG and HC Wainwright maintain buy ratings with targets of $42.00 and $46.00.

31.07.2026 г., 20:06 ч. UTC

Shares of Innoviva Inc. are trading lower, continuing a downward trend. The stock remains below its 20-day moving average amid no specific news.

30.07.2026 г., 19:02 ч. UTC

Innoviva Inc shares are declining amid market weakness and rising jobless claims. The stock remains near the lower end of its one-month range.

29.07.2026 г., 19:06 ч. UTC

Macro Event

Innoviva Inc shares are lower today as market scrutiny increases following the Federal Reserve's decision to maintain interest rates amid ongoing geopolitical tensions.

28.07.2026 г., 20:03 ч. UTC

Innoviva Inc shares are higher today, continuing an upward trend since Monday. No specific news was identified to explain the price movement.

27.07.2026 г., 19:56 ч. UTC

Innoviva Inc shares are lower today, reflecting broader market trends amid a significant drop in oil prices. No specific company news was identified.

21.07.2026 г., 15:46 ч. UTC

Innoviva Inc shares are higher today, reflecting a broader trend in rising equity indices. The stock remains below its 20-day moving average.

20.07.2026 г., 18:31 ч. UTC

Innoviva Inc shares are lower today, reflecting broader weakness in the Pharmaceuticals sub-sector. The stock has reversed from a recent trend of higher closes.

Сравнение с други в отрасъла

Ценова промяна

Innoviva Inc Прогноза

Ценова цел

By TipRanks

90.49% нагоре

12-месечна прогноза

Среден 40.67 USD  90.49%

Висок 46 USD

Нисък 34 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Innoviva Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

3

Купи

0

Задържане

0

Продай

Настроение

By Acuity

301 / 340 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Innoviva Inc

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; GIAPREZA (angiotensin II), a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock; XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections in adults; and XACDURO, a beta lactamase inhibitor for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Its development pipeline includes zoliflodacin, a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
help-icon Live chat